RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Respiratory Syncytial Virus (RSV) Infection Therapy Area Pipeline Report
Nov 2010 - 160 pages - $1,495
Respiratory Syncytial Virus (RSV) Infection - Pipeline Review, Q1 2011
Jan 2011 - 33 pages - $500
Respiratory Syncytial Virus (Rsv) Infection - Pipeline Review, Q3 2011
Jul 2011 - 82 pages - $500
Respiratory Syncytial Virus (RSV) Infection Global Clinical Trials Review, Q4, 2010
Dec 2010 - 48 pages - $1,000
Stakeholder Opinions: Respiratory viral infections - Respiratory syncytial virus, parainfluenza virus and human metapneumovirus as promising new targets
Apr 2010 - 139 pages - $3,800
West Nile Virus Global Clinical Trials Review, Q1, 2011
Apr 2011 - 24 pages - $1,000
Innovations in Molecular Diagnostics for Infectious Diseases
Nov 2011 - 168 pages - $3,835
Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success
Mar 2008 - 123 pages - $3,800
Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
Feb 2011 - 26 pages - $5,700
What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline
Feb 2010 - 220 pages - $4,200
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
X-ray del
Therapeutic target
Infectious diseases del
Bacteria or virus del
Respiratory syncytial virus RSV del
Development phase
Preclinical del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us